A5037515722- Prostate Cancer Treatment and Research
- Urinary Bladder and Prostate Research
- Prostate Cancer Diagnosis and Treatment
- Pelvic floor disorders treatments
- Pharmacology and Obesity Treatment
- Advanced Proteomics Techniques and Applications
- Intestinal and Peritoneal Adhesions
- Multiple and Secondary Primary Cancers
- Cancer-related gene regulation
- Bladder and Urothelial Cancer Treatments
- Radiopharmaceutical Chemistry and Applications
- Nausea and vomiting management
- Statistical Methods in Clinical Trials
- Cancer, Lipids, and Metabolism
- Dental Anxiety and Anesthesia Techniques
- Intestinal Malrotation and Obstruction Disorders
- Cardiovascular Syncope and Autonomic Disorders
- Health Systems, Economic Evaluations, Quality of Life
- Kidney Stones and Urolithiasis Treatments
- Blood Pressure and Hypertension Studies
- Hernia repair and management
- Ferroptosis and cancer prognosis
Complexo Hospitalario Universitario A Coruña
2009-2024
Hospital Universitario Lucus Augusti
2018-2023
Servicio Gallego de Salud
2021
Universidade da Coruña
2011
Because cystoscopy is expensive and invasive, a new method of detecting non-invasive muscular bladder cancer (NMIBC) needed. This study aims to identify potential serum protein markers for NMIBC improve diagnosis find treatment approaches that avoid disease progression life-threatening phenotype (muscle-invasive cancer, MIBC). Here, silver nanoparticles (AgNPs, 9.73 ± 1.70 nm) as scavenging device together with sequential window acquisition all theoretical mass spectra (SWATH-MS) were used...
OBJECTIVES: To describe a clinical case of ureteral inguinal hernia and to comment briefly about the topic. METHODS: 80 year-old patient with, hypertension, left sugery, right hemicolectomy for colon adenocarcinoma cholecystectomy. Intravenous urogram casually found that ureter was leaving abdominal cavity though duct then returned abdomen. RESULTS: CT scan confirmed diagnosis. Due advanced age patient, comorbidities absence symptoms, conservative treatment decided. CONCLUSIONS: Ureteral...
Aim: Darolutamide significantly prolonged metastasis-free survival (MFS) versus placebo in the Phase III ARAMIS study. We analyzed outcomes Spanish participants ARAMIS. Patients & methods: with high-risk nonmetastatic castration-resistant prostate cancer were randomized 2:1 to darolutamide 600 mg twice daily or placebo, plus androgen-deprivation therapy. The primary end point was MFS. Descriptive statistics are reported for this post hoc analysis. Results: In participants, (n = 75) MFS 42):...
You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Female Incontinence: Therapy I1 Apr 2017MP40-14 COGNITIVE EFFECTS OF TRANSDERMAL OXYBUTYNIN IN ELDERLY PATIENTS WITH OVERACTIVE BLADDER SYNDROME Carlos Muller-Arteaga, Jose Emilio Batista Miranda, Carmen Zubiaur, Ainara Rabade Ferreiro, Rafael El Khoury Moreno, Gonzalo Morales Solchaga, Javier Casas Nebra, Manuel Leva Vallejo, Oscar Gonzalez Garcia, Salvador Arlandis-Guzman, and Errando-Smet...